Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 4 | 2022 | 4268 | 0.840 |
Why?
|
Version, Fetal | 2 | 2020 | 22 | 0.830 |
Why?
|
Breech Presentation | 2 | 2020 | 40 | 0.820 |
Why?
|
Databases, Genetic | 4 | 2024 | 1758 | 0.810 |
Why?
|
High-Throughput Nucleotide Sequencing | 8 | 2015 | 3667 | 0.650 |
Why?
|
Hyperparathyroidism | 1 | 2020 | 339 | 0.640 |
Why?
|
Hyperuricemia | 1 | 2021 | 221 | 0.630 |
Why?
|
Graft Rejection | 2 | 2022 | 4498 | 0.610 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2020 | 340 | 0.580 |
Why?
|
Sequence Analysis, RNA | 4 | 2021 | 2040 | 0.560 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 190 | 0.560 |
Why?
|
Uric Acid | 1 | 2021 | 805 | 0.500 |
Why?
|
Nystagmus, Congenital | 1 | 2015 | 9 | 0.490 |
Why?
|
Sequence Analysis, DNA | 9 | 2019 | 4780 | 0.480 |
Why?
|
Molecular Sequence Annotation | 2 | 2018 | 526 | 0.480 |
Why?
|
Hereditary Central Nervous System Demyelinating Diseases | 1 | 2015 | 44 | 0.470 |
Why?
|
Genetic Association Studies | 3 | 2024 | 2744 | 0.460 |
Why?
|
Genetic Variation | 5 | 2018 | 6611 | 0.430 |
Why?
|
Neurofibromatosis 1 | 1 | 2018 | 561 | 0.430 |
Why?
|
Early Detection of Cancer | 2 | 2024 | 3236 | 0.400 |
Why?
|
Genetic Predisposition to Disease | 8 | 2020 | 18063 | 0.390 |
Why?
|
Prenatal Diagnosis | 1 | 2019 | 1271 | 0.390 |
Why?
|
RNA, Small Untranslated | 1 | 2012 | 77 | 0.370 |
Why?
|
Dystonia | 1 | 2015 | 378 | 0.370 |
Why?
|
Viruses | 1 | 2015 | 371 | 0.370 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2013 | 164 | 0.360 |
Why?
|
Microcephaly | 1 | 2015 | 426 | 0.360 |
Why?
|
Biological Evolution | 2 | 2015 | 1075 | 0.340 |
Why?
|
Decision Support Techniques | 1 | 2019 | 2006 | 0.320 |
Why?
|
Virus Diseases | 1 | 2015 | 722 | 0.310 |
Why?
|
Mutation, Missense | 3 | 2016 | 2592 | 0.310 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2764 | 0.300 |
Why?
|
Craniofacial Abnormalities | 2 | 2023 | 320 | 0.290 |
Why?
|
Magnesium | 2 | 2022 | 815 | 0.290 |
Why?
|
Mutation | 10 | 2019 | 30211 | 0.290 |
Why?
|
Acute Coronary Syndrome | 1 | 2020 | 2193 | 0.280 |
Why?
|
Genome, Viral | 3 | 2016 | 673 | 0.280 |
Why?
|
Graft Survival | 3 | 2022 | 3896 | 0.260 |
Why?
|
Virus Replication | 5 | 2019 | 2457 | 0.260 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2019 | 2441 | 0.260 |
Why?
|
Israel | 4 | 2021 | 726 | 0.250 |
Why?
|
RNA, Bacterial | 2 | 2021 | 393 | 0.240 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6966 | 0.230 |
Why?
|
Predictive Value of Tests | 5 | 2024 | 15424 | 0.200 |
Why?
|
Ectodermal Dysplasia | 1 | 2023 | 107 | 0.200 |
Why?
|
MicroRNAs | 5 | 2019 | 3792 | 0.200 |
Why?
|
Genome-Wide Association Study | 4 | 2017 | 12790 | 0.190 |
Why?
|
Mycoplasma | 2 | 2012 | 146 | 0.190 |
Why?
|
Software | 2 | 2012 | 4472 | 0.180 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4522 | 0.180 |
Why?
|
Pedigree | 7 | 2020 | 4539 | 0.180 |
Why?
|
Magnesium Deficiency | 1 | 2020 | 48 | 0.180 |
Why?
|
Birth Intervals | 1 | 2020 | 55 | 0.170 |
Why?
|
Retrospective Studies | 10 | 2024 | 81659 | 0.170 |
Why?
|
RNA, Viral | 3 | 2021 | 2867 | 0.170 |
Why?
|
Humans | 49 | 2024 | 767040 | 0.170 |
Why?
|
Ribonuclease III | 2 | 2019 | 271 | 0.160 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2019 | 86 | 0.160 |
Why?
|
Menstruation | 1 | 2020 | 310 | 0.160 |
Why?
|
Phenotype | 7 | 2024 | 16718 | 0.150 |
Why?
|
Chikungunya virus | 2 | 2016 | 56 | 0.150 |
Why?
|
DEAD-box RNA Helicases | 2 | 2019 | 385 | 0.150 |
Why?
|
Jews | 2 | 2020 | 359 | 0.150 |
Why?
|
Hyperkeratosis, Epidermolytic | 1 | 2017 | 7 | 0.150 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2019 | 165 | 0.150 |
Why?
|
Genital Neoplasms, Female | 1 | 2023 | 535 | 0.140 |
Why?
|
Genetic Testing | 3 | 2023 | 3591 | 0.140 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 245 | 0.140 |
Why?
|
Elliptocytosis, Hereditary | 1 | 2017 | 29 | 0.140 |
Why?
|
Amniotic Fluid | 1 | 2019 | 381 | 0.140 |
Why?
|
Nephritis, Hereditary | 1 | 2017 | 78 | 0.140 |
Why?
|
Evolution, Molecular | 2 | 2016 | 1893 | 0.140 |
Why?
|
Codon | 1 | 2018 | 599 | 0.140 |
Why?
|
Computational Biology | 4 | 2018 | 3567 | 0.140 |
Why?
|
Ichthyosis | 1 | 2016 | 59 | 0.130 |
Why?
|
Leucovorin | 1 | 2018 | 644 | 0.130 |
Why?
|
Mumps virus | 1 | 2016 | 23 | 0.130 |
Why?
|
Cohort Studies | 5 | 2024 | 41718 | 0.130 |
Why?
|
Deafness | 1 | 2020 | 460 | 0.130 |
Why?
|
Calpain | 1 | 2016 | 146 | 0.130 |
Why?
|
Parity | 1 | 2019 | 931 | 0.130 |
Why?
|
DNA Mutational Analysis | 5 | 2017 | 4114 | 0.130 |
Why?
|
Complement Factor I | 1 | 2015 | 14 | 0.130 |
Why?
|
Mucopolysaccharidosis III | 1 | 2015 | 11 | 0.120 |
Why?
|
Murine hepatitis virus | 1 | 2015 | 19 | 0.120 |
Why?
|
Abortion, Spontaneous | 1 | 2020 | 534 | 0.120 |
Why?
|
Enterovirus B, Human | 1 | 2015 | 49 | 0.120 |
Why?
|
Parvovirus, Canine | 1 | 2014 | 2 | 0.120 |
Why?
|
Hair | 1 | 2019 | 508 | 0.120 |
Why?
|
Exons | 2 | 2018 | 2391 | 0.120 |
Why?
|
Organometallic Compounds | 1 | 2018 | 648 | 0.120 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2015 | 57 | 0.120 |
Why?
|
Arboviruses | 1 | 2014 | 13 | 0.120 |
Why?
|
Alopecia | 1 | 2019 | 416 | 0.120 |
Why?
|
HIV | 2 | 2012 | 1591 | 0.120 |
Why?
|
Adaptation, Biological | 1 | 2015 | 147 | 0.120 |
Why?
|
Arbovirus Infections | 1 | 2014 | 21 | 0.120 |
Why?
|
Female | 22 | 2024 | 396660 | 0.110 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1144 | 0.110 |
Why?
|
Porokeratosis | 1 | 2013 | 3 | 0.110 |
Why?
|
Down-Regulation | 2 | 2019 | 2931 | 0.110 |
Why?
|
Desmoglein 1 | 1 | 2013 | 7 | 0.110 |
Why?
|
Acetyltransferases | 1 | 2015 | 230 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 376 | 0.110 |
Why?
|
Parathyroid Hormone | 1 | 2020 | 1804 | 0.110 |
Why?
|
RNA Viruses | 1 | 2015 | 110 | 0.110 |
Why?
|
Culicidae | 1 | 2014 | 111 | 0.110 |
Why?
|
Viral Nonstructural Proteins | 1 | 2015 | 228 | 0.110 |
Why?
|
Keratosis | 1 | 2013 | 81 | 0.110 |
Why?
|
Hypopigmentation | 1 | 2013 | 43 | 0.110 |
Why?
|
Delivery, Obstetric | 1 | 2020 | 949 | 0.110 |
Why?
|
Fluorouracil | 1 | 2018 | 1652 | 0.110 |
Why?
|
Pyrophosphatases | 1 | 2013 | 142 | 0.110 |
Why?
|
Hearing Loss | 1 | 2020 | 785 | 0.100 |
Why?
|
Calcification, Physiologic | 1 | 2013 | 170 | 0.100 |
Why?
|
Wasting Syndrome | 1 | 2013 | 96 | 0.100 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2017 | 386 | 0.100 |
Why?
|
Population Dynamics | 1 | 2015 | 314 | 0.100 |
Why?
|
Middle Aged | 11 | 2024 | 223233 | 0.100 |
Why?
|
Prenatal Care | 1 | 2020 | 1158 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2019 | 659 | 0.100 |
Why?
|
RNA Editing | 1 | 2014 | 149 | 0.100 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2013 | 205 | 0.100 |
Why?
|
Pityriasis Rubra Pilaris | 1 | 2012 | 20 | 0.100 |
Why?
|
RNA-Binding Proteins | 2 | 2019 | 1889 | 0.100 |
Why?
|
Virulence | 1 | 2016 | 1294 | 0.100 |
Why?
|
Internet | 1 | 2024 | 3114 | 0.100 |
Why?
|
Placenta | 1 | 2021 | 1726 | 0.100 |
Why?
|
Immunoglobulins | 1 | 2015 | 853 | 0.100 |
Why?
|
Adenosine Deaminase | 1 | 2014 | 253 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2227 | 0.100 |
Why?
|
Linear Models | 1 | 2021 | 5875 | 0.090 |
Why?
|
Pre-Eclampsia | 1 | 2021 | 1255 | 0.090 |
Why?
|
Dermatitis | 1 | 2013 | 203 | 0.090 |
Why?
|
Retinitis Pigmentosa | 1 | 2015 | 395 | 0.090 |
Why?
|
Guanylate Cyclase | 1 | 2012 | 206 | 0.090 |
Why?
|
Syndrome | 2 | 2015 | 3271 | 0.090 |
Why?
|
Tubulin | 1 | 2015 | 694 | 0.090 |
Why?
|
INDEL Mutation | 1 | 2012 | 266 | 0.090 |
Why?
|
Pancreatic Neoplasms | 2 | 2019 | 5446 | 0.090 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2012 | 165 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2014 | 343 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2021 | 2099 | 0.090 |
Why?
|
Risk Assessment | 2 | 2024 | 24299 | 0.090 |
Why?
|
Antibodies | 1 | 2019 | 2419 | 0.090 |
Why?
|
ROC Curve | 1 | 2018 | 3618 | 0.090 |
Why?
|
Vaccinia virus | 1 | 2012 | 328 | 0.090 |
Why?
|
Phylogeny | 2 | 2016 | 2840 | 0.090 |
Why?
|
Genome, Human | 2 | 2014 | 4441 | 0.090 |
Why?
|
Ear, Inner | 1 | 2014 | 426 | 0.090 |
Why?
|
Gestational Age | 1 | 2019 | 3618 | 0.090 |
Why?
|
Recombination, Genetic | 1 | 2014 | 1524 | 0.080 |
Why?
|
Point Mutation | 1 | 2015 | 1591 | 0.080 |
Why?
|
Epithelium | 1 | 2014 | 1606 | 0.080 |
Why?
|
HIV-1 | 2 | 2019 | 6951 | 0.080 |
Why?
|
Male | 17 | 2024 | 364203 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4210 | 0.080 |
Why?
|
Registries | 2 | 2023 | 8351 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20169 | 0.080 |
Why?
|
Aged | 7 | 2024 | 171319 | 0.080 |
Why?
|
Ultrasonography | 1 | 2021 | 6000 | 0.080 |
Why?
|
Adult | 12 | 2023 | 223317 | 0.070 |
Why?
|
Ethics, Medical | 1 | 2013 | 785 | 0.070 |
Why?
|
Macular Degeneration | 1 | 2015 | 1015 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2014 | 836 | 0.070 |
Why?
|
Host-Pathogen Interactions | 2 | 2014 | 1466 | 0.070 |
Why?
|
Protein Conformation | 1 | 2015 | 3948 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12536 | 0.070 |
Why?
|
Sequence Alignment | 1 | 2011 | 2176 | 0.070 |
Why?
|
Base Sequence | 5 | 2015 | 12414 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4881 | 0.070 |
Why?
|
Lung | 2 | 2023 | 10076 | 0.070 |
Why?
|
Herpesvirus 4, Human | 1 | 2012 | 1079 | 0.070 |
Why?
|
Genomics | 3 | 2023 | 5924 | 0.060 |
Why?
|
Pregnancy | 4 | 2021 | 30238 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2023 | 9612 | 0.060 |
Why?
|
Skin | 2 | 2017 | 4499 | 0.060 |
Why?
|
Gene Frequency | 1 | 2013 | 3621 | 0.060 |
Why?
|
Incidence | 1 | 2024 | 21526 | 0.060 |
Why?
|
Molecular Sequence Data | 5 | 2016 | 17608 | 0.060 |
Why?
|
Antiviral Agents | 2 | 2015 | 3070 | 0.060 |
Why?
|
Risk Factors | 3 | 2024 | 74886 | 0.060 |
Why?
|
Skin Diseases | 1 | 2013 | 1083 | 0.060 |
Why?
|
Coronary Vessels | 1 | 2016 | 3114 | 0.060 |
Why?
|
Models, Molecular | 1 | 2015 | 5388 | 0.060 |
Why?
|
Killer Cells, Natural | 1 | 2014 | 2209 | 0.060 |
Why?
|
Genome | 1 | 2013 | 1752 | 0.060 |
Why?
|
Cell Line | 3 | 2015 | 15567 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2016 | 4525 | 0.060 |
Why?
|
Pancreatectomy | 2 | 2019 | 825 | 0.060 |
Why?
|
Hypersensitivity | 1 | 2013 | 1169 | 0.060 |
Why?
|
Prognosis | 3 | 2020 | 29963 | 0.060 |
Why?
|
Transcription Factors | 2 | 2023 | 12158 | 0.050 |
Why?
|
Gene Expression Profiling | 3 | 2016 | 9532 | 0.050 |
Why?
|
Child, Preschool | 5 | 2020 | 42606 | 0.050 |
Why?
|
Family | 1 | 2013 | 3210 | 0.050 |
Why?
|
Genes, Homeobox | 1 | 2023 | 289 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9464 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2015 | 4401 | 0.050 |
Why?
|
Proteins | 1 | 2017 | 6001 | 0.050 |
Why?
|
Body Mass Index | 1 | 2019 | 13048 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 16036 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6360 | 0.040 |
Why?
|
Genetic Markers | 2 | 2017 | 2602 | 0.040 |
Why?
|
Receptors, Thrombopoietin | 1 | 2021 | 159 | 0.040 |
Why?
|
Age of Onset | 2 | 2019 | 3344 | 0.040 |
Why?
|
HeLa Cells | 2 | 2019 | 3073 | 0.040 |
Why?
|
Antibodies, Fungal | 1 | 2019 | 33 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12250 | 0.040 |
Why?
|
Platelet Count | 1 | 2021 | 784 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2023 | 59548 | 0.040 |
Why?
|
beta Catenin | 1 | 2023 | 1048 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2021 | 65295 | 0.040 |
Why?
|
Keratin-1 | 1 | 2017 | 3 | 0.040 |
Why?
|
Keratin-10 | 1 | 2017 | 8 | 0.040 |
Why?
|
RNA, Untranslated | 1 | 2021 | 455 | 0.040 |
Why?
|
Face | 1 | 2023 | 1029 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 740 | 0.040 |
Why?
|
Genotype | 3 | 2019 | 13035 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2018 | 418 | 0.040 |
Why?
|
Animals | 8 | 2016 | 168965 | 0.030 |
Why?
|
Heredity | 1 | 2017 | 149 | 0.030 |
Why?
|
Specimen Handling | 1 | 2021 | 706 | 0.030 |
Why?
|
Pancreatic Ducts | 1 | 2018 | 330 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6573 | 0.030 |
Why?
|
Mumps Vaccine | 1 | 2016 | 16 | 0.030 |
Why?
|
Defective Viruses | 1 | 2016 | 89 | 0.030 |
Why?
|
Scalp | 1 | 2019 | 390 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14672 | 0.030 |
Why?
|
Intermediate Filament Proteins | 1 | 2016 | 261 | 0.030 |
Why?
|
Young Adult | 3 | 2023 | 59980 | 0.030 |
Why?
|
Tunisia | 1 | 2015 | 36 | 0.030 |
Why?
|
Portal Vein | 1 | 2018 | 437 | 0.030 |
Why?
|
Consensus Sequence | 1 | 2016 | 363 | 0.030 |
Why?
|
Caribbean Region | 1 | 2016 | 193 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13650 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2012 | 7868 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 17097 | 0.030 |
Why?
|
Vero Cells | 1 | 2016 | 486 | 0.030 |
Why?
|
Mutagenesis | 1 | 2019 | 1227 | 0.030 |
Why?
|
Vaccines, Attenuated | 1 | 2016 | 314 | 0.030 |
Why?
|
Pancreaticoduodenectomy | 1 | 2018 | 515 | 0.030 |
Why?
|
HIV Infections | 2 | 2019 | 17542 | 0.030 |
Why?
|
Hair Follicle | 1 | 2016 | 219 | 0.030 |
Why?
|
Mutagens | 1 | 2015 | 181 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 2016 | 1168 | 0.030 |
Why?
|
Signal Transduction | 2 | 2014 | 23621 | 0.030 |
Why?
|
Cambodia | 1 | 2014 | 185 | 0.030 |
Why?
|
Breast | 1 | 2023 | 1972 | 0.030 |
Why?
|
Microbial Viability | 1 | 2015 | 236 | 0.030 |
Why?
|
Genetic Privacy | 1 | 2014 | 59 | 0.030 |
Why?
|
Insect Vectors | 1 | 2014 | 136 | 0.030 |
Why?
|
Aedes | 1 | 2014 | 101 | 0.030 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2016 | 566 | 0.030 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 104 | 0.030 |
Why?
|
Adolescent | 3 | 2020 | 89046 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2015 | 487 | 0.030 |
Why?
|
Somatomedins | 1 | 2013 | 179 | 0.030 |
Why?
|
Skin Diseases, Genetic | 1 | 2013 | 49 | 0.030 |
Why?
|
Cicatrix | 1 | 2019 | 798 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2019 | 3431 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 202 | 0.030 |
Why?
|
Vestibule, Labyrinth | 1 | 2014 | 235 | 0.020 |
Why?
|
Polysaccharides | 1 | 2019 | 1020 | 0.020 |
Why?
|
Heterozygote | 1 | 2019 | 2794 | 0.020 |
Why?
|
Drug Combinations | 1 | 2018 | 2086 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 588 | 0.020 |
Why?
|
Blood Platelets | 1 | 2021 | 2464 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1743 | 0.020 |
Why?
|
Child | 5 | 2020 | 80771 | 0.020 |
Why?
|
Bacteria | 1 | 2021 | 2212 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3611 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2824 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3552 | 0.020 |
Why?
|
Dogs | 1 | 2014 | 3834 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22254 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2015 | 12793 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2972 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2014 | 751 | 0.020 |
Why?
|
Saliva | 1 | 2014 | 853 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2012 | 661 | 0.020 |
Why?
|
Gene Deletion | 1 | 2017 | 2668 | 0.020 |
Why?
|
Mammals | 1 | 2014 | 1135 | 0.020 |
Why?
|
Epidemics | 1 | 2014 | 516 | 0.020 |
Why?
|
Mice | 4 | 2016 | 81912 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2019 | 2678 | 0.020 |
Why?
|
Cochlea | 1 | 2014 | 848 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2012 | 1494 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36582 | 0.020 |
Why?
|
Mass Screening | 1 | 2023 | 5456 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2902 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2015 | 11923 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5022 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 26325 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2016 | 1761 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 22361 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4143 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2829 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4280 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6777 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5693 | 0.020 |
Why?
|
Zebrafish | 1 | 2016 | 3036 | 0.010 |
Why?
|
Viral Load | 1 | 2014 | 3385 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10393 | 0.010 |
Why?
|
Retina | 1 | 2015 | 2659 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12823 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11063 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11217 | 0.010 |
Why?
|
Infant | 2 | 2013 | 36485 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9410 | 0.010 |
Why?
|
Rats | 1 | 2016 | 23713 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54886 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6260 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11872 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10254 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39317 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4713 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2018 | 15824 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15925 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18330 | 0.010 |
Why?
|
United States | 1 | 2023 | 72971 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26396 | 0.010 |
Why?
|